期刊文献+

SIRT2沉默对胃癌SGC-7901细胞增殖、迁移和侵袭的影响 被引量:3

Influences of SIRT2 silence on proliferation, migration and invasion of gastric cancer SGC-7901 cells
下载PDF
导出
摘要 目的探究沉默信息调节蛋白2(SIRT2)对人胃癌SGC-7901细胞增殖、迁移和侵袭的影响及机制。方法采用实时荧光定量PCR(q RT-PCR)检测SIRT2在胃癌SGC-7901细胞和正常胃上皮GES-1细胞中的表达。采用RNA干扰技术处理SGC-7901细胞,SIRT2沉默组转染靶向SIRT2的干扰小RNA(SIRT2-siRNA1组、SIRT2-siRNA2组),阴性对照组转染SIRT2-si RNA阴性对照序列,空白对照组不转染。CKK-8法和平板细胞克隆形成实验检测SGC-7901细胞增殖, Transwell法检测SGC-7901细胞侵袭迁移能力,蛋白印迹检测SGC-7901细胞中SIRT2、丝氨酸/苏氨酸蛋白激酶(Akt)和磷脂酰肌醇-3激酶(PI3K)蛋白表达。结果人胃癌细胞SNU-1、KATO III、SGC-7901中SIRT2m RNA和蛋白水平均高于正常胃上皮GES-1细胞(P<0.05)。转染SIRT2-si RNA的SGC-7901细胞中SIRT2m RNA和蛋白水平均低于阴性及空白对照组(P<0.05);转染SIRT2-si RNA后,SGC-7901细胞增殖能力、克隆形成能力、迁移和侵袭能力均降低(P<0.05);转染SIRT2-siRNA后SGC-7901细胞中Akt、PI3K蛋白磷酸化程度显著下降(P <0.05)。结论 SIRT2在胃癌细胞中表达上调,沉默SIRT2可能通过调节PI3K/Akt通路抑制胃癌细胞增殖、迁移和侵袭,推测SIRT2可能作为潜在靶标应用于胃癌的基因治疗。 Objective To investigate the influences and mechanisms of silencing sirtuin-2(SIRT2) on proliferation, migration and invasion of human gastric cancer SGC-7901 cells. Methods The expressions of SIRT2 in gastric cancer SGC-7901 cells and normal gastric epithelial GES-1 cells was detected by real-time fluorescence quantitative PCR (qRT-PCR). The SGC-7901 cells were treated with RNA interference technique, the SIRT2 silence group was transfected with interfering small RNAs targeting SIRT2 (group SIRT2-siRNA1, group SIRT2-siRNA2), the negative control group was transfected with SIRT2-siRNA negative control sequence, blank control group was not transfected. CKK-8 assays and panel cell colony formation experiments were used to detect the proliferation of SGC-7901 cells. Transwell assay was applied to detect the invasion and migration abilities of SGC-7901 cells. The expressions of SIRT2, serine/threonine rotein kinase (Akt) and phosphatidylinositol-3 kinase (PI3K) in SGC-7901 cells were detected by Western blot. Results SIRT2 mRNA and protein levels in human gastric cancer cells SNU-1, KATO III and SGC-7901 were higher than those in normal gastric epithelial GES-1 cells (P 〈 0.05). The levels of SIRT2 mRNA and protein in SGC-7901 cells transfected with SIRT2-siRNA were lower than those in negative and blank control groups (P 〈 0.05); after SIRT2-siRNA transfection, the proliferation, clonality, migration and invasion of SGC-7901 cells were decreased (P 〈 0.05); after transfection of SIRT2-siRNA, the phosphorylation of Akt and PI3K proteins in SGC-7901 cells were decreased significantly (P 〈 0.05). Conclusion SIRT2 is up-regulated in gastric cancer cells and SIRT2 silence may inhibit proliferation, migration and invasion of gastric cancer cells by regulating PI3K/Akt pathway, on which it is speculated that SIRT2 may be used as a potential target for gene therapy of gastric cancer.
作者 牛虹 杨峰 唐静雯 田同德 李华华 岳光星 范伊晓 周浩本 NIU Hong;YANG Feng;TANG Jing-wen;TIAN Tong-de;LI Hua-hua;YUE Guang-xing;FAN Yi-xiao;ZHOU Hao-ben(Oncology Department of Integrated Traditional Chinese and Western Medicine,Cancer Center of Zhengzhou University,Henan 450008,China)
出处 《中国医药生物技术》 2018年第6期526-531,共6页 Chinese Medicinal Biotechnology
关键词 沉默信息调节蛋白2 胃癌 增殖 侵袭 迁移 Sirtuin-2 Gastric cancer Proliferation Invasion Migration
  • 相关文献

参考文献3

二级参考文献45

  • 1Eirini Pantazi,Mohamed Amine Zaouali,Mohamed Bejaoui,Emma Folch-Puy,Hassen Ben Abdennebi,Joan Roselló-Catafau.Role of sirtuins in ischemia-reperfusion injury[J].World Journal of Gastroenterology,2013,19(43):7594-7602. 被引量:8
  • 2王洪义,李明,顾晋.胃癌肝转移患者的手术治疗及预后分析[J].中华胃肠外科杂志,2005,8(1):11-13. 被引量:22
  • 3万能斌,舒琼,莫胜川,周征宇.外科治疗胃癌肝转移疗效分析[J].中国现代手术学杂志,2005,9(3):210-212. 被引量:2
  • 4郑朝旭,袁兴华,孙跃民,崔修铮,赵平.手术治疗胃癌肝转移的预后分析[J].中国肿瘤临床,2005,32(14):821-823. 被引量:16
  • 5Ueda K, lwahashi M, Nakamori M, et al. Analysis of the prognos- tic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer [ J ]. Langenbecks Arch Surg, 2009,394(4) :647-653.
  • 6Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics,2002 [J]. CA CancerJClin,2005,55(2):74-108.
  • 7Shitara K, Ikeda J, Kondo C, et al. Reporting patient characteris- tics and stratification factors in randomized trials of systemic chem- otherapy for advanced gastric cancer [ J ]. Gastric Cancer,2012,15 (2) : 137-143.
  • 8Japanese Gastric Cancer Association. Japanese gastric cancer treat- ment guidelines (Ver. 3)[J]. Gastric Cancer,2011,14(2) :113- 123.
  • 9Ajani JA, Barthel JS, Bekaii-Saab T, et al. Gastric cancer[J]. J Nat1 Compr Canc Netw ,2010,8 (4) :378-409.
  • 10Saiura A, Umekita N, lnoue S, et al. Clinicopathologieal features and outcome of hepatic resection for liver metastasis tTom gastric cancer [ J ]. Hepatogastroenterology, 2002,49 ( 46 ) : 1062 - 1065.

共引文献32

同被引文献32

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部